Analyst Ratings for Iterum Therapeutics (ITRM)
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
N/A
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
N/A
Rating Score: 2.9 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/30/2026 | H.C. Wainwright | Matthew Keller | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.04 (0.03) |
-25% | Details |
| 3/4/2026 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
0.15 (0.03) |
-80% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


